Search by Drug Name or NDC

    NDC 66215-0604-06 UPTRAVI 400 ug/1 Details

    UPTRAVI 400 ug/1

    UPTRAVI is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actelion Pharmaceuticals US, Inc.. The primary component is SELEXIPAG.

    Product Information

    NDC 66215-0604
    Product ID 66215-604_f9b62ce2-37c1-2e5c-e053-6394a90a657b
    Associated GPIs 40120070000315
    GCN Sequence Number 075313
    GCN Sequence Number Description selexipag TABLET 400 MCG ORAL
    HIC3 B1C
    HIC3 Description PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE
    GCN 40356
    HICL Sequence Number 042922
    HICL Sequence Number Description SELEXIPAG
    Brand/Generic Brand
    Proprietary Name UPTRAVI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Selexipag
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 400
    Active Ingredient Units ug/1
    Substance Name SELEXIPAG
    Labeler Name Actelion Pharmaceuticals US, Inc.
    Pharmaceutical Class Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207947
    Listing Certified Through 2024-12-31

    Package

    NDC 66215-0604-06 (66215060406)

    NDC Package Code 66215-604-06
    Billing NDC 66215060406
    Package 1 BOTTLE in 1 CARTON (66215-604-06) / 60 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2015-12-21
    NDC Exclude Flag N
    Pricing Information N/A